From evidence to commitment to action: implementing HIV prevention measures in prisons in Ukraine XVI International AIDS Conference Toronto, 15 August.

Slides:



Advertisements
Similar presentations
Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.
Advertisements

HIV in Europe Stockholm, 3.November 2009 Communication on combating HIV/AIDS in the EU and the neighbourhood - strategy and second action plan ( )
Workshop IV: Provision of Health Care The Impact of International Standards and Guidelines on prisoner health in Eastern and Central Europe Antalya, Turkey.
Unprevented and prevented HIV cases in Europe and Central Asia Unprevented and prevented HIV cases in Europe and Central Asia Ani SHAKARISHVILI, MD UNAIDS.
Needle and syringe programmes in prisons
MDM Harm Reduction (needle exchange) program in Kabul-Afghanistan.
Organizing Drug Users for Community & Social Change.
In prison drugs do not enter! that's what the authorities mostly say… Daniela De Santis Prevention coordinator Switzerland January 2014.
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
1 On Point: making prison needle and syringe programs work in Canada January 23rd, 2014 Sandra Ka Hon Chu Canadian HIV/AIDS Legal Network.
Harm Reduction in Prisons: Prisoners’ Rights are Human Rights Rick Lines, MA Executive Director, Irish Penal Reform Trust December 11 th 2003.
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
HIV, Drugs & Prisons Photo by Mr. Alessandro Scotti, UNODC Good Will Ambassador Gino Vumbaca.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
Drug policy and harm reduction: impact of the US policy Raminta Stuikyte Central and Eastern European Harm Reduction Network.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
HIV AIDS Section Fabienne Hariga Senior Adviser UNODC HIV AIDS section, Vienna Comprehensive package of interventions for HIV in prison settings AIDS 2012.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
Code of Good Practice for NGOs Responding to HIV/AIDS.
HIV and drug prevention in Estonia Harm reduction services
Treatment of drug addiction in prisons
Violation of Rights of People Living with HIV/AIDS in Health Care Setting in Odessa, Ukraine Odessa, Ukraine August 2008 Kostiantyn Zverkov, Director of.
HIV/AIDS STI & Viral Hepatitis WHO/Europe HIV/HCV coinfection in Europe Dr Irina Eramova August 4, 2008 XVII International AIDS Conference, Mexico.
Harm Reduction.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.
Annual report 2010: the state of the drugs problem in Europe.
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
November 2012 Prepared for the Contra Costa Board of Supervisors by Contra Costa Health Department Needle Exchange Update.
Medical Professionalism and its Relationship to Public Health: Physician Advocacy and State Public Health Policy Thomas Kellogg Program Officer and Advisor.
PROGRAM UPDATE OVERCOMING HIV/AIDS EPIDEMICS IN UKRAINE NATIONAL PROGRAM SUPPORTED BY GFATM COMPONENT: TREATMENT, CARE AND SUPPORT Presentation by Treatment,
Early TB detection and treatment efficiency enhancement among the most at risk populations in Ukraine AIDS 2014, Melbourne 22 July 2014.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
Targeted Interventions for IDUs – an overview. Targeted Intervention for IDUs - an Overview 2 Background  In Asia, 4.7 million people were infected with.
Implementation of the Substitution Maintenance Therapy in the framework of the Programme “Overcoming HIV/AIDS Epidemics in Ukraine” Stakeholders meeting.
National roll-out of database for HIV prevention programmes among civil society organizations in Ukraine Olga Varetska ICF “International HIV/AIDS Alliance.
© 2005, CARE USA. All rights reserved. Inter country consultation on preventing HIV among IDU from evidence to action Bangladesh Presentation.
1 People who use drugs, HIV, and human rights The Lancet : HIV in people who use drugs Vienna, 20 July 2010 Ralf Jürgens Joanne Csete, Joe Amon Steven.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
Harm Reduction International
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
AIDS 2014 Workshop on increasing access to TB services as part of integrated care for people who inject drugs Integrating TB services.
2010 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Ecdc.europa.eu Epidemiological Situation of HIV/AIDS in the EU and its Neighbouring Countries German Presidency Conference Responsibility & Partnership.
1 Background & history of the debate Geneva, 14 October 2009 Ralf Jürgens.
Organizing Drug Users for Public Health Policy Changes 17 th International Conference on the Reduction of Drug Related Harm Jason Farrell, Executive Director.
Health in Prisons Project Oslo, 24 November 2009 Lars Moller Regional Adviser a.i. World Health Organization Regional Office for Europe Health in Prisons.
Controlling HIV/AIDS in Russia: Strategic Chokepoints & Opportunities Olusoji Adeyi Health Program Team Leader for Russia The World Bank, Washington, DC.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
1 A Public Health and Human Rights Imperative: The Case for Prison Needle and Syringe Programs XVII International AIDS Conference Tuesday, August 5, 2008.
Abstract #TUPDE202: Collaboration and Cross Training between Health and Correctional Services Leads to More Integrated Services for PHAs in Prison: Poster.
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
General Situation (Overview)
Eurasian Harm Reduction Network (EHRN)
Needle and syringe exchange and working with injecting drug users
Evidence for Action: Effectiveness of HIV/AIDS interventions in prison settings In 2005, WHO commissioned a review of the evidence of the effectiveness.
Global burden of HIV, viral hepatitis and TB in prisoners
Addressing Drug Use Together Through a Health Based Approach:
Olga Varetska International HIV/AIDS Alliance in Ukraine
Community Action on Harm Reduction (CAHR) Programme
Global epidemiology of injecting drug use
Dr Lars Moller, PhD Project Manager Health in Prisons Project
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Towards a Conducive Legal and Structural Environment
The HIV Epidemic among People who Inject Drugs
Collaborative TB/HIV activities in European Region
Presentation transcript:

From evidence to commitment to action: implementing HIV prevention measures in prisons in Ukraine XVI International AIDS Conference Toronto, 15 August 2006 Jürgens R, Kozhan N, Klisha V, Ivantchenko S, Serdiuk V, MacDonald M Centre for Research into Quality

Acknowledgements Funders Canadian International Development Agency International Harm Reduction Development Swiss Cooperation United Nations Development Programme World Health Organization International Renaissance Foundation Lead agencies Canadian HIV/AIDS Legal Network State Department of Ukraine for Enforcement of Sentences Centre for Research into Quality

Background Ukraine has one of the highest HIV rates in Europe. Injecting drug use remains the most common source of infection, contributing to 57.1% of infections among adults (WHO, 2006) Average prevalence of HIV among IDU: 37.2% (2002) HIV epidemic accompanied by high incarceration rate: 419 per 100,000 (Walmsley, 2005) Centre for Research into Quality

HIV and HCV Prevalence Research in 5 regions, 7 prisons (2005) n=831 blood testing –HIV: between 16 and 32% (5 regions) –HCV: between 75.5 and 91.5% (2 regions) self-reported status (anonymous questionnaire) –5% HIV, 8% HCV Centre for Research into Quality

Drug Use in Prisons Drugs can and do enter into prisons. Many prisoners are in prison because of offences related to drugs. People who use drugs outside often find a way to continue drug use inside. Other prisoners start using drugs in prison. Centre for Research into Quality

Injecting Drug Use in Prison Injecting is generally less frequent in prison than in the community, but injecting is more risky due to the scarcity of injecting equipment. Many start injecting in prison. Prisoners have far more changes in injecting partners than IDUs in the community. There is considerable interaction between prisoner and community injecting populations. Centre for Research into Quality

HIV Transmission in Prison Outbreaks of HIV infection in prisons in Scotland, Australia, Lithuania, Russia. Ukraine: cohort study in 2 prisons –400 blood samples in Dec 2004, 276 in August 2005 –6 cases of infection (2 in prison 1, 4 in prison 2) Centre for Research into Quality

Prison Conditions Contribute to the Problems Severe overcrowding Lack of work and meaningful activities Abuse & corruption Prisoner-on-prisoner violence Decaying physical infrastructure Lack of medical care Lack of nutritious food & clean water Centre for Research into Quality

Prevention: providing needles & syringes PNSPs have been introduced in over 50 prisons in eight countries: Switzerland, Germany, Spain, Moldova, Kyrgystan, Belarus, Iran, and Luxembourg. ∙Other countries have announced that pilot projects will start soon, including Armenia, Ukraine, and Portugal. Centre for Research into Quality

Evaluation of PNSPs (2) Evaluations have shown: –syringe sharing was “strongly reduced” –no new cases of HIV infection –decrease in fatal and non-fatal heroin overdoses –decrease in abscesses and other injection- related infections –facilitation of referral of users to treatment programs Centre for Research into Quality

PNSPs (3) no negative impact on safety and security; in particular, needles have not been used as weapons no reported increase in drug use or injecting Centre for Research into Quality

Preparing for PNSPs: Activities partnership between the Ukrainian prison system, Ukrainian NGOs, and the Canadian HIV/AIDS Legal Network research on prevalence and incidence study tours conference on HIV and harm reduction in prisons selection of sites for pilot projects Centre for Research into Quality

Preparing for PNSPs: Activities (2) trainings for staff at the prisons and for senior staff of the Ukrainian prison system development of legal framework development of monitoring and evaluation framework Centre for Research into Quality

Results initial resistance to implementation of pilot projects could be overcome projects scheduled to start in 2006 other positive effects: sterile equipment for medical services political uncertainty has delayed implementation Centre for Research into Quality

Conclusions effective partnerships can be created between prison systems, NGOs in Eastern Europe and NGOs in Western countries a series of well-planned steps, including research, study tours, and trainings, can create the conditions for implementation of PNSPs monitoring and evaluation are important for efforts to scale up such programs political considerations may further delay implementation of such programs Centre for Research into Quality

For more info … Contact Morag MacDonald at or Ralf Jürgens at Visit the prison section of the website of the Canadian HIV/AIDS Legal Network: Centre for Research into Quality